CAI
Caris Life Sciences, Inc. NASDAQ Listed Jun 18, 2025$19.85
Mkt Cap $5.6B
52w Low $16.28
13.6% of range
52w High $42.50
50d MA $19.11
200d MA $26.37
P/E (TTM)
-9.7x
EV/EBITDA
3927.4x
P/B
53.5x
Debt/Equity
0.7x
ROE
-11.8%
P/FCF
674.4x
RSI (14)
—
ATR (14)
—
Beta
1.33
50d MA
$19.11
200d MA
$26.37
Avg Volume
2.3M
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
750 West John Carpenter Freeway · Irving, TX 75039 · US
Data updated apr 24, 2026 11:41pm
· Source: massive.com